{"name":"Tourmaline Bio, Inc.","slug":"tourmaline-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-10-29","type":"pipeline","source":"simplywall.st","summary":"Tourmaline Bio (TRML): Evaluating Valuation After Recent Strong Share Price Gains - simplywall.st","headline":"Tourmaline Bio (TRML): Evaluating Valuation After Recent Strong Share Price Gains","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-30","type":"deal","source":"Medical Dialogues","summary":"Novartis commences tender offer to buy Tourmaline Bio - Medical Dialogues","headline":"Novartis commences tender offer to buy Tourmaline Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQcEw5dkZodGlVcHpndDFEVnVsdzBYSjRYWG53TmRkTFJtM3U2QWhmYjhyUEVla2MyMVczTGtVM25zVVdlWGtlU0ZNa0JfeDdZTDZIVWF3Z1VVRXFNZVVVUk5sV0xKVmhNUTVUenU3cndXZWo2ZWsyYUtyRFNRZEUzNl9oZy1GNW9OQi1WMzJnaXVacktqVWpv?oc=5","date":"2025-09-09","type":"deal","source":"BioPharma Dive","summary":"Novartis to gain heart drug in $1.4B deal for Tourmaline Bio - BioPharma Dive","headline":"Novartis to gain heart drug in $1.4B deal for Tourmaline Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxPYkZHbzVQdzl2UWt5STcyTFUwR1F0THRzQk5nZXZ3UklFQTNCOGUyUFcyUm9rd01taVppSklwcTlqU095d1R6eWh6ZHZBUDFMV1VGOUExWmJBUW5Nb2lzQmZyTVNFbks1STE5c0tmUmJQdGdfSVU4ZjdYTml5TjRmR2I5N1ZhZ0xXMmVJN0RRWEpZLU5tMXBfMGIydW9fRy1IaXpleWJnUjJ3aXFHelJUWVh1N1FydG1QY0liX0dBQnpydk1aZV9BTWJULWJFWDNGb204clhIbndFazRrWnE1djB6OG1Ed3UxTk5lX2h0WHlmQlp6cmZPb3B3R1dCT0pBaXExemdKM2FwVk5STEE?oc=5","date":"2025-09-09","type":"deal","source":"Novartis","summary":"Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD) - Novartis","headline":"Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPOU5VT1pTOHBSSTJMazBzNHhwY1U4Y2lRcU0xZEFibmN2a1ZycE5Md2V2WVBaZ1FvQ0tSdnpQdzdsU0dlbWlpbHBlV0pWSUR1QW9zSUVnSmJtV0lpWkRyNGhhX3Jqc0t2cUNwT290d2JYVWZ5YUhFNVRTWllxTHFYbllyaGVxM3pwc2pLNklXdnNFXzhubE1aX3h3UnRVVmIxYlBIbFg0S2dTaU0yYllwU1VBOGE?oc=5","date":"2025-09-09","type":"deal","source":"Reuters","summary":"Novartis to acquire Tourmaline Bio for $1.4 billion - Reuters","headline":"Novartis to acquire Tourmaline Bio for $1.4 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPVjRSZ2JOUy1yRlFPVzU3bWRfOXdqQWpUbFVZX055R3NuSUptcDVHVGdlR0ZQUXZkYnlSQ1dLMmJzV1k2elA1ZUtEUFNuYXAtRGxRcl96MnZKZ3ktRXZfVjZNVVprLUZEMkJSN2h0aTM5LUE0cTFEZjVhY2RfUl81c1VDbkRRWjVPM1ZrYlg4Xy15MlRWMVpOcEJCSVk?oc=5","date":"2025-09-09","type":"deal","source":"Contract Pharma","summary":"Novartis to Acquire Tourmaline Bio for $1.4 Billion - Contract Pharma","headline":"Novartis to Acquire Tourmaline Bio for $1.4 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPelQ3dFdNcDh1MmtVSVV5bkFqMDZuSlRfOHdFRmRKZHVkOWZ6RXFRRTQ5QlN6VVh5MU9BU3lrQzBSclBOQm9saXdfenJQTVNzRFdrMmRhNlM4Y0ZLTUNkbU05NVlxNnhWc3RkVXctQ24tMjRxdEhjZjFCZC1ZbEtmTXRmN3hNTW1xX0RranR6VVhYdW41ZkVNdGdmMlVmYWJYMWkyTk13VENnSXUtRmc?oc=5","date":"2025-09-09","type":"trial","source":"Fierce Biotech","summary":"Novartis spends $1.4B for Tourmaline and cardiovascular med that impressed in phase 2 - Fierce Biotech","headline":"Novartis spends $1.4B for Tourmaline and cardiovascular med that impressed in phase 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQYWhqM0VIUDF4OExjaVpPUlZVbWtjSDExNkNSakVHQnUxTUdHVVkwbVJsVG1yVnR0VnFxaWJoR3lpcHB6c2kzWVJ2cUNqcXNXZjc2d0hIVHJCakctWlhkNHRkMnZBVE9uRGp5aFRxQWZzWmZXX0EtNDRpOWJ4ZzRSYi1yb2RJcFc2a1hB?oc=5","date":"2025-09-09","type":"pipeline","source":"Barron's","summary":"This Biopharma Stock Is Soaring 58%. Novartis Is Acquiring It. - Barron's","headline":"This Biopharma Stock Is Soaring 58%. Novartis Is Acquiring It. - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxObXFBMHh0dGQwb1VhT1I2eHRsQmRaZ2FYSGxkYXFoenVEUmlOaXNwYkJSMFlHZWlXZXF5X1hXbWM1dDFWdHRNRU5LZi1hV0phUGxTbDA1djNaTDJsdFE3akZwZXh0SWdtTnBfVnljbmFTT2Q4REtiUjItR3o5XzRlNjFocmQzRHR3d1JuRDRVNXhXSmdoMGo5cmdYQzRvbThoWGNwUE9SdU9iYTgwTTNWVmMyeEVxSnhRTWxybGQ0OTRzT0FxZmxfMWd1b05iNXFLa2R2Vmh3?oc=5","date":"2025-09-09","type":"pipeline","source":"European Pharmaceutical Review","summary":"Novartis expands in cardiovascular disease with $1.4bn Tourmaline Bio acquisition - European Pharmaceutical Review","headline":"Novartis expands in cardiovascular disease with $1.4bn Tourmaline Bio acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOS1VVU0ZOZ2RZSUVlZXlqV2hSaWtmREFvUTN3X2dFWFY1OU1Ec0UwLTZ6VnNycDNLOTZkWmdYYktpdXc4ZUdUNk5ZamJDQTIxdVEwVTRoYkFZMC13SFFLVFlIOENxUnB1eEdKWmNrQ2diV3UyQTBBcjBXcDhhU2t6Z2ZyRjRybmJNcDhYakZrVHZWalU?oc=5","date":"2025-09-09","type":"pipeline","source":"Investopedia","summary":"This Small Biotech Stock Is Surging Today. Here's Why. - Investopedia","headline":"This Small Biotech Stock Is Surging Today. Here's Why.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPTG1NY05XbFg1bHpGOXZObkdYZkloZ2loNHNBMHZWNm1NblRHRE83R2I0UGJMUUtEUk1HendnUWs2Y24tQVBVa2V0VFFfUjZxSnktU29qbXJZcGs5cjVqSk9hek9xdW5EMWpxX3V6RFRrOWs0YklGVnZITDV3MGNWVDZnY1hCVzZyR2NiMEZ1T09NcU96ZURsNGdfY1QtclQ3aVJsY1ZubFc0Rnp5Q3BhemlEWFRzZFNpTnZnZGQwTlNmdw?oc=5","date":"2025-09-09","type":"deal","source":"Seeking Alpha","summary":"Buyout Of Tourmaline By Novartis Primarily On Pacibekitug IL-6 Novel Mode Of Action (TRML) - Seeking Alpha","headline":"Buyout Of Tourmaline By Novartis Primarily On Pacibekitug IL-6 Novel Mode Of Action (TRML)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFA5blVqcFVaNUVZVWdlTjluTHJQRGJwRDdIY0o5dUdOcFZ4RWU5OHVPMFFPNmV1TFk5dmFMUXQ1RXpOc192QlZqU24zS2l5Y01WczY2UUE2UTJ3TGNuMDdubjlxNVhSam5qN3VhRjBMU0VHdTQwbzFkTVRDX2c?oc=5","date":"2025-02-11","type":"pipeline","source":"Pharma Voice","summary":"In the crowded cardio space, it’s David vs. Goliath for small biotechs - Pharma Voice","headline":"In the crowded cardio space, it’s David vs. Goliath for small biotechs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}